|
| |
|
ZyCare has developed the CoagCare® system to facilitate
"Supervised Patient Self-Management"™ of warfarin therapy.
CoagCare is a browser-based, "Direct-to-Patient Expert System"™
that
structures the management of patients using home self INR testing devices. |
|
| |
|
| |
| |
What is CoagCare? |
|
|
|
|
| |
 |
CoagCare is the only FDA cleared direct-to-patient, rules-based expert system for the long-term management of patients undergoing oral anticoagulation therapy with warfarin. CoagCare enables healthcare professionals to safely and cost-effectively supervise remotely located patients who are using approved self-testing devices, as well as patients who are being traditionally managed in a physician’s office or medical clinic. |
|
| |
|
TOP |
|
|
| |
|
| |
| |
Key features of CoagCare |
|
|
|
|
| |
 |
Cleared by the Food and Drug Administration |
|
| |
 |
Easy to use patient interface |
|
| |
 |
Caregiver interface allows for continuous monitoring of patient progress |
|
| |
 |
Medication dosage and test-scheduling algorithms can be personalized for each patient |
|
| |
 |
Automatic problem screening with patient issues prioritized to allow for prompt caregiver
attention to those patients who need it |
|
| |
 |
Can be used with any approved home INR device |
|
| |
 |
Point-of-care module for managing patients who come to the clinic |
|
| |
 |
HIPAA compliant, secure, electronic medical record |
|
| |
 |
Web-based system accessible anywhere, anytime, by patients and caregivers |
|
| |
|
TOP |
|
|
| |
|
| |
| |
Advantages |
|
|
|
|
| |
Patients |
|
| |
 |
Fewer clinic visits |
|
| |
 |
Closer medical supervision |
|
| |
 |
Freedom to travel while maintaining
contact with caregiver |
|
| |
 |
Empowers patients to manage their
own therapy |
|
| |
|
|
| |
Caregivers |
|
| |
 |
Increased staff efficiency |
|
| |
 |
Seamless integration of point-of-care and
remote patient management |
|
| |
 |
Focus time on patients needing attention |
|
| |
 |
Medicare reimbursement available |
|
| |
|
TOP |
|
| |
|
|
|
| |
|
|
|
|